Research Progresses in Traditional Chinese Medicine in Treating Atherosclerosis

Jingyue Yu, Xueqin Chen, Huan Lei, Lei Li, Haihong Fang

2022

Abstract

Atherosclerosis (AS) is the major cause of cardiovascular and cerebrovascular diseases, and its formation process mainly involves several stages such as intimal injury, inflammation induction and plaque formation. The cells to play crucial role in the occurrence of AS mainly include endothelial cells, immune cells and vascular smooth muscle cells. Traditional Chinese medicine (TCM) is characterized by multi-components and multi-targets and have significant advantages in the clinical treatment of AS. The paper reviews the regulatory effects of TCM on major cells involved in AS, which provides a reference for future in-depth studies of treating AS by TCM.

Paper Citation

in Harvard Style

Yu J., Chen X., Lei H., Li L. and Fang H. (2022). Research Progresses in Traditional Chinese Medicine in Treating Atherosclerosis. In Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB; ISBN 978-989-758-637-8, SciTePress, pages 178-182. DOI: 10.5220/0012015900003633

in Bibtex Style

@conference{icbb22,
author={Jingyue Yu and Xueqin Chen and Huan Lei and Lei Li and Haihong Fang},
title={Research Progresses in Traditional Chinese Medicine in Treating Atherosclerosis},
booktitle={Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB},
year={2022},
pages={178-182},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0012015900003633},
isbn={978-989-758-637-8},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB
TI - Research Progresses in Traditional Chinese Medicine in Treating Atherosclerosis
SN - 978-989-758-637-8
AU - Yu J.
AU - Chen X.
AU - Lei H.
AU - Li L.
AU - Fang H.
PY - 2022
SP - 178
EP - 182
DO - 10.5220/0012015900003633
PB - SciTePress